Sign in
4

Changes in Ownership

CRESCENT BIOPHARMA, INC. Filed Acc 0001628280-26-044890

Chief Financial Officer sold 1,112 shares at $17.99 ($20,005)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Scalzo Richard William · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-22 Sale : show line 1 in the form 10b5-1 −1,112 $17.99 $20,005 20,298 D
Open-market sales · 1,112 sh · avg $17.99 · $20,005
Loading xslF345X06/wk-form4_1782245034.xml…